Haemonetics Corporation (HAE)

Haemonetics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020
Market Capitalization	3,166	4,335	4,175	3,263	5,694	5,078
Market Cap Growth	-10.21%	3.83%	27.92%	-42.69%	12.14%	13.79%
Enterprise Value	4,137	5,011	4,717	3,809	5,827	5,392
Last Close Price	63.02	85.35	82.75	63.85	112.04	100.95
PE Ratio	24.82	36.87	36.17	75.24	71.65	66.35
Forward PE	13.10	20.49	25.45	23.82	33.88	29.04
PS Ratio	2.33	3.31	3.57	3.29	6.54	5.14
PB Ratio	3.49	4.51	5.10	4.36	7.78	8.65
P/TBV Ratio	-	-	54.93	-	-	20.87
P/FCF Ratio	38.02	37.54	25.63	43.08	79.34	46.39
P/OCF Ratio	24.50	23.85	15.29	18.95	52.33	32.09
PEG Ratio	0.99	1.39	2.42	1.36	2.46	1.82
EV/Sales Ratio	3.01	3.83	4.04	3.84	6.69	5.46
EV/EBITDA Ratio	11.95	16.96	18.72	19.87	31.60	20.90
EV/EBIT Ratio	17.26	24.23	28.21	36.22	58.21	32.53
EV/FCF Ratio	49.67	43.40	28.96	50.28	81.19	49.26
Debt / Equity Ratio	1.43	0.91	1.02	1.12	1.08	0.78
Debt / EBITDA Ratio	3.63	2.86	3.16	4.14	4.02	1.72
Debt / FCF Ratio	15.53	7.57	5.10	11.07	10.98	4.17
Asset Turnover	0.58	0.63	0.62	0.54	0.56	0.78
Inventory Turnover	1.82	2.07	1.98	1.50	1.49	2.15
Quick Ratio	2.11	1.29	1.85	0.95	1.26	1.10
Current Ratio	3.97	2.56	3.06	1.71	2.74	2.20
Return on Equity (ROE)	14.06%	13.22%	14.72%	5.86%	12.05%	12.20%
Return on Assets (ROA)	6.33%	6.26%	5.51%	3.57%	4.05%	8.15%
Return on Capital (ROIC)	7.46%	7.42%	6.46%	4.23%	4.88%	10.02%
Return on Capital Employed (ROCE)	10.50%	10.90%	9.90%	7.40%	6.40%	16.70%
Earnings Yield	4.11%	2.71%	2.76%	1.33%	1.40%	1.51%
FCF Yield	2.63%	2.66%	3.90%	2.32%	1.26%	2.16%
Buyback Yield / Dilution	0.27%	0.04%	-0.13%	-0.12%	1.01%	2.13%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q